HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons.

Abstract
Despite advances in understanding the signaling mechanisms involved in the development and maintenance of chronic pain, the pharmacologic treatment of chronic pain has seen little advancement. Agonists at the mu opioid receptor (MOPr) continue to be vital in the treatment of many forms of chronic pain, but side-effects limit their clinical utility and range from relatively mild, such as constipation, to major, such as addiction and dependence. Additionally, chronic activation of MOPr results in pain hypersensitivity known as opioid-induced hyperalgesia (OIH), and we have shown recently that recruitment of β-arrestin2 to MOPr, away from transient potential vanilloid eceptor type 1 (TRPV1) in primary sensory neurons contributes to this phenomenon. The delta opioid receptor (DOPr) has become a promising target for the treatment of chronic pain, but little is known about the effects of chronic activation of DOPr on nociceptor sensitivity and OIH. Here we report that chronic activation of DOPr by the DOPr-selective agonist, SNC80, results in the sensitization of TRPV1 and behavioral signs of OIH via β-arrestin2 recruitment to DOPr and away from TRPV1. Conversely, chronic treatment with ARM390, a DOPr-selective agonist that does not recruit β-arrestin2, neither sensitized TRPV1 nor produced OIH. Interestingly, the effect of SNC80 to sensitize TRPV1 is species-dependent, as rats developed OIH but mice did not. Taken together, the reported data identify a novel side-effect of chronic administration of β-arrestin2-biased DOPr agonists and highlight the importance of potential species-specific effects of DOPr agonists.
AuthorsMatthew P Rowan, Kalina Szteyn, Allison P Doyle, Ruben Gomez, Michael A Henry, Nathaniel A Jeske
JournalMolecular pain (Mol Pain) Vol. 10 Pg. 50 (Aug 01 2014) ISSN: 1744-8069 [Electronic] United States
PMID25085415 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Arrb2 protein, mouse
  • Arrb2 protein, rat
  • Arrestins
  • Benzamides
  • Lectins
  • Piperazines
  • Receptors, Opioid, mu
  • Sensory System Agents
  • TRPV Cation Channels
  • TRPV1 protein, mouse
  • Trpv1 protein, rat
  • beta-Arrestin 2
  • beta-Arrestins
  • 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
  • Capsaicin
Topics
  • Animals
  • Arrestins (metabolism)
  • Benzamides (pharmacology)
  • Capsaicin (toxicity)
  • Cells, Cultured
  • Disease Models, Animal
  • Hyperalgesia (chemically induced, drug therapy)
  • Lectins (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pain Threshold (drug effects)
  • Piperazines (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, mu (agonists)
  • Sensory Receptor Cells (drug effects)
  • Sensory System Agents (toxicity)
  • Species Specificity
  • TRPV Cation Channels (metabolism)
  • Time Factors
  • Trigeminal Ganglion
  • beta-Arrestin 2
  • beta-Arrestins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: